Your shipment just got detained at a US port of entry. The FDA has flagged a label claim. Customs wants documentation you don’t have. And every day it sits there, you’re losing money.

This isn’t a hypothetical. It happens to international health brands every single week with genuinely good products, real customers, and serious ambitions for the US market. They simply didn’t know what they didn’t know about US compliance before they shipped.

US compliance for health and nutrition products is not a checklist you fill out once. It’s a layered system of FDA regulations, customs requirements, labelling standards, and liability rules that interact with each other, and getting any one of them wrong can stop your entire US launch cold.

 At TruLife Distribution, specialists in FDA compliant US health brand distribution, navigating this system for international brands is a core part of what the team does every day. Here’s what you need to understand before a single unit leaves your facility.

Why US compliance trips up even experienced brands

Most international health brands have already navigated compliance in their home country. They have certifications, lab results, and approved labels. They assume the US market will require something similar, just a translation of what they’ve already done.

That assumption is expensive.

The US FDA operates under a framework that is structurally different from most other regulatory systems. It doesn’t pre-approve dietary supplements before they reach the market, but it holds manufacturers and importers to strict post-market accountability for ingredients, claims, and labelling. The result: a product can look fully compliant and still trigger FDA action over a single label claim, an ingredient name, or a formatting detail.

The FDA doesn’t warn you before it acts. It detains, recalls, and issues warning letters. By the time you find out there’s a problem, the damage is already in motion.

Rule 1: Your label is a legal document, treat it that way

In the US, a supplement or nutrition product label is not just packaging. It’s a regulatory declaration that your product meets specific federal standards. Every element is governed by what you can claim, how you must list ingredients, the exact format of the Supplement Facts panel, font sizes, serving size declarations, and the required placement of certain information.

What most brands get wrong on labels

• Structure/function claims stated as disease claims. Saying your product “supports healthy blood pressure” is legally different from saying it “lowers blood pressure.” The second is a drug claim and it will get your product flagged immediately.
• Ingredient names not matching FDA’s established nomenclature. Using a branded ingredient name or a regional name for a compound that has a specific FDA-recognised term creates a compliance gap, even if the ingredient itself is permitted.
• Missing or incorrectly formatted Supplement Facts panel. The FDA has precise requirements for the layout, order of nutrients, and daily value declarations. A panel that looks complete to the eye can still be technically non-compliant.
•  No US responsible party listed. Every product sold in the US must identify a domestic responsible party, a US-based entity that can receive FDA communications. International brands without a US partner often skip this entirely.

Label review is not optional and it needs to be done by someone who knows current FDA guidelines specifically, not just general regulatory principles.

Rule 2: Not every ingredient legal elsewhere is legal in the US

This is the compliance rule that surprises brands most often and causes the most serious problems.

The FDA maintains a list of prohibited or restricted ingredients for US dietary supplements. Many are commonly used across Europe, Asia, and other markets that are legal there, heavily restricted or banned here.

Beyond banned ingredients, the FDA’s “new dietary ingredient” rule requires brands to file a formal notification 75 days before marketing any compound introduced to the US market after October 1994. Most international brands have never heard of it.

Shipping a product with a non-compliant or unreported new dietary ingredient doesn’t just create a label problem. It can result in detention at the border, mandatory recall, and in serious cases, injunctive action against the company.

Ingredient compliance review checking every compound in your formulation against current FDA permitted ingredient lists is a non-negotiable step before importing.

Rule 3: US Customs and FDA work together

Many brands treat FDA compliance and customs clearance as two separate processes. They’re not. US Customs and Border Protection works in coordination with the FDA to screen imported health and food products. When a shipment arrives at a US port of entry, customs can and will routinely flag it for FDA review based on product type, country of origin, labelling, or prior compliance history.

Common triggers for FDA examination at port of entry:

•  Prior import alerts on the brand or manufacturer, if your product has been flagged before, every future shipment faces automatic scrutiny.
•  Label anomalies visible during customs review such as mismatched product descriptions, missing required information, or claims that suggest a drug rather than a supplement.
• Missing or incomplete entry documentation including incorrect Harmonized Tariff System codes, missing FDA establishment registration, or absent prior notice for food products.
•  Country of origin flags certain manufacturing countries facing elevated scrutiny due to historical compliance issues in that market.

Getting customs clearance right means documentation prepared before the shipment leaves, not after detention begins.

Rule 4: Product liability exposure is real 

 The moment your product is sold to a US consumer through any channel you fall under US legal jurisdiction for any claims related to it. A consumer complaint has full legal recourse in US courts regardless of where your company is headquartered.

Without US-specific product liability insurance, a single claim can cost more to defend than an entire year of US revenue. Most international brands don’t discover this gap until they need coverage and don’t have it.

Product liability insurance for US market sales is not a “later” item. It belongs in place before your first unit ships.

The right way to handle US compliance 

Compliance is not a problem to solve reactively. By the time you’re facing an FDA detention, the damage is already more expensive than prevention ever was.

The brands that enter the US market cleanly and stay in it follow a specific sequence:

• Full ingredient audit against current FDA permitted and prohibited ingredient lists, including NDI status review.
• Complete label redesign or review by a US-based FDA compliance specialist; not a general regulatory consultant.
• US responsible party designation, typically handled by a US distribution partner.
• Customs documentation preparation: correct HS codes, FDA establishment registration, prior notice filing where required.
• Product liability insurance in place before the first shipment.

Each step requires current, specific FDA knowledge rules that change and are interpreted differently across district offices.

Don’t let compliance be the reason your US launch fails

TruLife Distribution handles FDA label compliance review, ingredient audits, customs documentation, US responsible party designation, and product liability coverage for every brand we work with  before a single unit enters the US.

 If you want your US launch done right from day one, start at trulifedist.com.

Compliance isn’t the obstacle between you and the US market. Done correctly, it’s the foundation your entire US business is built on.

Robert Haynes, a psychology graduate from the University of Hertfordshire, has a keen interest in the fields of mental health, wellness, and lifestyle.